共 50 条
- [31] Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC).JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 522S - 522SCastro, GSnitcovsky, IMLGebrim, EMLeitao, GMRocha, CNNadalin, WFerraz, ARFederico, MHH
- [32] Response of chemoradiation therapy after induction chemotherapy failure in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Lim, YoojooKeam, BhumsukKoh, YoungilLee, Kyung-HunKim, Tae MinLee, Se-HoonHah, Jeong-HunKwon, Tack-KyunKim, Dong-WanWu, Hong-GyunSung, Myung-WhunHeo, Dae SeogKim, Kwang Hyun
- [33] Definitive chemoradiotherapy with either high-dose or weekly cisplatin in patients with locally advanced squamous cell head and neck cancer: A retrospective analysisEUROPEAN JOURNAL OF CANCER, 2015, 51 : S575 - S575van Marcke, C.Petit, B.Confente, C.Filleul, B.Neybuch, Y.Christian, N.Rosier, J. F.Mitine, C.Seront, E.
- [34] Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinomaHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E970 - E980Viana, Luciano de Souzade Aguiar Silva, Felipe Coelhodos Anjos Jacome, Alexandre AndradeCampelo Maia, Danielle Calheirosde Mattos, Marcos DuarteJacinto, Alexandre ArthurMamere, Augusto EliasBoldrini Junior, Domingosde Castro Capuzzo, RenatoSantos, Carlos RobertoCarvalho, Andre Lopes
- [35] Neoadjuvant docetaxel, cisplatin, and 5-fluorouracil before concurrent chemoradiotherapy or concurrent cetuximab-radiotherapy in locally advanced squamous cell carcinoma of the head and neckJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Billan, S.Abdah-Bortnyak, R.Mezid, F.Bernstein, Z.Gez, E.Nasrallah, H.Kuten, A.
- [36] ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced (LA) squamous cell carcinoma of the head and neck (HNSCC)ANNALS OF ONCOLOGY, 2021, 32 : S789 - S790Forster, M.Mendes, R.Urbano, T. GuerreroEvans, M.Lei, M.Spanswick, V.Miles, E.Simoes, R.Wheeler, G.Forsyth, S.White, L.
- [37] Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Garcia, Enrique SanzZou, JinfengAvery, LisaSpreafico, AnnaWaldron, JohnGoldstein, David PaulHansen, Aaron RichardCho, Johnde Almeida, John R.Hope, AndrewHosni, AliHahn, EzraPerez-Ordonez, BayardoZhao, ZhenSmith, Christopher GarethZheng, YangqiaoRosenfeld, NitzanSingaravelan, NittushaBratman, Scott VictorSiu, Lillian L.
- [38] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and NeckJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 416 - 421Komatsu, MasanoriShiono, OsamuTaguchi, TakahideSakuma, YasunoriNishimura, GoushiSano, DaisukuSakuma, NaokoYabuki, KenichiroArai, YasuhiroTakahashi, MasahiroIsitoya, JunichiOridate, Nobuhiko
- [39] Factors associated with hospitalization in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) treated with definitive chemoradiation (CRT).JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Park, Soo J.Parikh, MiliHarrington, JoanneHeppner, PiaMcCarthy, KellyCrandall, BaileyWong-Sefidan, Ida
- [40] Retrospective analysis of the addition of cetuximab to induction chemotherapy (IC) with docetaxel, cisplatin, and 5-fluorouracil (TPF-C) for locally advanced squamous cell carcinoma of the head and neck (LA-HNSCC)JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Kuperman, D. I.Nussenbaum, B.Thorstad, W.Haughey, B.Lewis, J.Adkins, D.